A counterweight to market volatility
With significant market power across the drug supply chain, pharmaceutical manufacturers have sole discretion over medication pricing. That’s why it’s so important that we serve as the counterweight — and we are. Through negotiations, we’re lowering prescription drug prices and improving health outcomes:
- For every $1 spent, pharmacy benefit managers (PBMs) reduce costs by $10.
- Over the next 10 years, PBMs will help prevent 1 billion medication errors.
- 9 in 10 employers are satisfied with their PBM.
- We pass through 98% of the negotiated discounts and pharmacy rates to clients.
Aligned scale FAQ
All large PBMs have scale. Optum Rx is different because our scale is aligned, transparently and intentionally, to client outcomes. We combine:
- Buying power
- Enterprise‑level technology investment
- Deep clinical and operational expertise
- Clear economics
The value flows to our clients and their members. For our highly managed clients, this looks like 19% PMPM savings.1
We connect plan sponsors, pharmacies and pharmaceutical companies while offering real-time visibility into pricing and choices, supported by digital tools that help members act earlier and with confidence.
Medication affordability means balancing 3 things:
- Sustainable plan costs
- Manageable member out‑of‑pocket expenses
- Access to clinically appropriate care
Optum Rx focuses on lowering total net spend, not just shifting costs, so plans can remain sustainable while members can afford and stay on their medications. Despite rising costs, Optum Rx members can expect to spend an average of $15 per prescription.3
We apply our buying power across brands, specialty medications, biosimilars and generics to negotiate aggressively and protect clients from pricing volatility. But scale alone is not the advantage; it's how it’s used that matters.
At Optum Rx, we align that purchasing power to client priorities, translating scale into:
- Lower net cost
- Greater predictability
- Long‑term affordability
As a plan sponsor, you can leverage our scale, technology and clinical management programs to reduce your pharmacy benefit spend. We have:
- Invested $1.5B to advance our capabilities
- Over 17,000 expert AI engineers
- More than 1,000 solutions in action
This helps us to provide predictive trend modeling, real-time benefit tools, proactive clinical intervention and more to improve experiences for everyone we serve.
At Optum Rx, we lower pharmacy benefit costs by intentionally applying our scale, clinical expertise and technology without limiting access to the medications members need.
We combine strong manufacturer negotiations, clinical first benefit design and real time decision support to steer utilization toward the most effective, lowest net cost therapies while protecting member choice and adherence.
Optum Rx helps lower costs for members by combining national buying power with real‑time pricing tools, clinical programs and network strategies that turn scale into savings at the point of care.
We negotiate aggressively to:
- Lower net medication costs
- Make lower‑cost options visible before prescriptions are filled
- Guide members to safe, effective, more affordable therapies
As a result, members pay $15 per prescription, on average.3
Optum Rx manages specialty medication costs through:
- Integrated clinical oversight
- Site‑of‑care optimization
- Medication adherence support
- Coordinated pharmacy services
This approach helps reduce unnecessary use while improving outcomes for members managing complex conditions.
Specialty medications drive a disproportionate share of pharmacy spend.
Industry insights
Article
New pills and expanded indications are poised to alter the dynamics of GLP-1 costs and treatments.
Article
We delivered a seamless 1/1 transition for over 800 new clients with strong service, stable operations and improved member experiences.
Article
The move to Maximum Fair Prices for popular drugs will trigger new economic considerations for plan sponsors.
Article
Two AI experts share insights on how we’re using AI and advanced technology to improve everything from trend prediction to member services.
Article
Rising pharmacy costs extend far beyond GLP-1s — inflammatory conditions and oncology therapies continue to drive significant spend.
Complementary solutions
Weight Engage
Get the most from these pricey new obesity drugs by choosing the right coverage strategy and helping your members build lifelong habits.
Pharmacy benefits backed by data and insight
We help members, providers and clients act with clarity and confidence — earlier and faster.
- 2025 analysis.
- KLAS Research, 2024.
- 2024 analysis.